Attached files

file filename
10-Q/A - FORM 10-Q/A - ChromaDex Corp.cdxc10q_apr22016.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 240.13A14 OR 240.15D14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED - ChromaDex Corp.ex31-2.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 240.13A14 OR 240.15D14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED - ChromaDex Corp.ex31-1.htm
EX-10.6 - SECOND AMENDMENT TO NIAGEN SUPPLY AGREEMENT - ChromaDex Corp.ex10-6.htm
EX-10.5 - FIRST AMENDMENT TO NIAGEN SUPPLY AGREEMENT - ChromaDex Corp.ex10-5.htm
EX-10.4 - ADDENDUM TO THE NIAGEN SUPPLY AGREEMENT - ChromaDex Corp.ex10-4.htm
Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002)

In connection with this Amendment No. 1 on Form 10-Q/A of ChromaDex Corporation (the “Company”) for the quarter ended April 2, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Frank L. Jaksch Jr., Chief Executive Officer of the Company, and Thomas C. Varvaro, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002, that, to our knowledge:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

Date: August 26, 2016
/s/ FRANK L. JAKSCH JR.
Frank L. Jaksch Jr.
Chief Executive Officer

/s/ THOMAS C. VARVARO
Thomas C. Varvaro
Chief Financial Officer
 
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.